T. Rowe Price Investment Management’s UnitedHealth UNH Stock Holding History

T. Rowe Price Investment Management’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$935M	Sell	3,455,149 -653,880	-16%	-$195M	0.64%	32
2025 Q4	$1.36B	Buy	4,109,029 +2,410,128	+142%	+$817M	0.86%	25
2025 Q3	$587M	Sell	1,698,901 -545,388	-24%	-$165M	0.36%	76
2025 Q2	$700M	Sell	2,244,289 -632,213	-22%	-$242M	0.44%	55
2025 Q1	$1.51B	Sell	2,876,502 -1,909,438	-40%	-$976M	1%	13
2024 Q4	$2.42B	Buy	4,785,940 +723,115	+18%	+$411M	1.49%	8
2024 Q3	$2.38B	Sell	4,062,825 -733,386	-15%	-$415M	1.43%	6
2024 Q2	$2.44B	Buy	4,796,211 +275,309	+6%	+$135M	1.54%	6
2024 Q1	$2.24B	Buy	4,520,902 +287,476	+7%	+$146M	1.37%	4
2023 Q4	$2.23B	Sell	4,233,426 -308,795	-7%	-$165M	1.45%	5
2023 Q3	$2.29B	Sell	4,542,221 -20,839	-0.5%	-$10.3M	1.62%	4
2023 Q2	$2.19B	Buy	4,563,060 +66,296	+1%	+$32.4M	1.49%	6
2023 Q1	$2.13B	Buy	4,496,764 +1,829,600	+69%	+$883M	1.52%	6
2022 Q4	$1.41B	Sell	2,667,164 -101,292	-4%	-$53.7M	1.09%	15
2022 Q3	$1.4B	Buy	+2,768,456	New	+$1.46B	1.12%	18

Other funds holding UNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Investment Management's UNH Position: Q1 2026 in Review

T. Rowe Price Investment Management reduced its UnitedHealth (UNH) stake by 16% in Q1 2026, selling an estimated $195M and leaving 3,455,149 shares worth $935M. The position accounts for 0.64% of the portfolio, ranked #32.

T. Rowe Price Investment Management first reported a position in UNH in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.44B in Q2 2024. 3,032 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

T. Rowe Price Investment Management held 3,455,149 shares of UnitedHealth worth $935M as of Q1 2026.
T. Rowe Price Investment Management sold 653,880 UnitedHealth shares in Q1 2026, an estimated $195M.
UnitedHealth made up 0.64% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #32 holding.
T. Rowe Price Investment Management first reported a position in UnitedHealth in Q3 2022 and has held it in 15 quarters since.
T. Rowe Price Investment Management's UnitedHealth position peaked at $2.44B in Q2 2024.
3,032 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.